

Biological Buffers Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Biological Buffers market is expected to reach a value of $200 million by 2025, with a compound annual growth rate of 5%. The market is driven by the increasing demand for biological buffers in pharmaceutical and biotechnology industries, as well as the rising prevalence of chronic diseases. Various market conditions such as key players, market trends, and growth opportunities are covered in the research report.
Request Sample Report
◍ Avantor
◍ Alfa Aesar (Thermo Fisher)
◍ Merck
◍ Lonza
◍ Bio-Rad
◍ BD
◍ GE Healthcare
◍ Promega Corporation
◍ Hamilton Company
◍ XZL BIO-TECHNOLOGY
◍ SRL
Competitive Landscape: Avantor, Alfa Aesar (Thermo Fisher), Merck, Lonza, Bio-Rad, BD, GE Healthcare, Promega Corporation, Hamilton Company, XZL BIOTECHNOLOGY, SRL operate in Biological Buffers Market. They provide high-quality buffers for research, pharmaceuticals, biotechnology, and diagnostic applications, contributing to market growth.
Sales Revenue:
- Avantor: $6.8 billion
- Thermo Fisher (parent company of Alfa Aesar): $24.5 billion
- Merck: $17.9 billion
◍ Research Institution
◍ Pharmaceutical Industry
◍ Others
◍ Phosphates Type
◍ Acetates Type
◍ TRIS Type
◍ Others
Request Sample Report